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Objective: Recommended timing of coronary revascularization after transmural
acute myocardial infarction ranges from immediate surgical intervention to repair 4
weeks after infarction. Such wide variation has created a dilemma in the manage-
ment of these patients. The objective of this study was to delineate the optimal
timing of revascularization after transmural acute myocardial infarction in a large
and contemporary patient population.
Methods: We performed a retrospective multicenter analysis of 32,099 patients who
underwent coronary artery bypass grafting as the sole procedure after transmural
myocardial infarction between 1991 and 1996 by 179 surgeons at 33 hospitals in
New York State.
Results: Overall hospital mortality for all patients who underwent coronary revas-
cularization with a history of transmural myocardial infarction was 3.3%. Hospital
mortality decreased with increasing time interval between revascularization and
transmural acute myocardial infarction: 14.2%, 13.8%, 7.9%, 3.8%, 2.9%, and 2.7%
for less than 6 hours, 6 hours to 1 day, 1 to 3 days, 4 to 7 days, 7 to 14 days, and
greater than 15 days, respectively. Multivariate analyses of 43 potential risk factors
suggests that revascularization within 3 days of transmural acute myocardial infarc-
tion is independently associated with mortality.
Conclusions: Coronary revascularization within 3 days of a transmural acute myo-
cardial infarction might be an added risk for mortality. In the absence of absolute
indications for emergency surgical intervention, such as structural complications
and ongoing ischemia, a 3-day waiting period before surgical revascularization
should be considered.
Higher mortality for emergency coronary artery bypass grafting(CABG) after acute myocardial infarction (AMI), ranging from5% to 30%, has been documented since the early 1970s.1-4 Amongthis patient population, those who had a transmural AMI weremore likely to present with cardiogenic shock and to have a worseprognosis.5-9 Many have advocated preoperative support with
intra-aortic balloon counterpulsation10-12 and left ventricular assist device inser-
tion.13,14 Another potential strategy to improve outcome has been manipulation of
the timing of CABG after AMI.3-5,8,15,16 However, recommended timing of surgical
From the Department of Surgery, College
of Physicians and Surgeons, Columbia Uni-
versity, New York City, NY.
Read at the Eighty-first Annual Meeting of
The American Association for Thoracic
Surgery, San Diego, Calif, May 6-9, 2001.
Received for publication May 14, 2001;
revisions requested June 25, 2001; revi-
sions received April 2, 2002; accepted for
publication April 18, 2002.
Address for reprints: Daniel C. Lee, MD,
c/o Dr Ting, 630 West 168th St, P&S 17-
401, New York, NY 10032 (E-mail:
dcl64@columbia.edu, wt60@columbia.edu).
J Thorac Cardiovasc Surg 2003;125:115-20
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.000
doi:10.1067/mtc.2003.75
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 1 115
A
CD
intervention after a transmural AMI ranges from immediate
intervention5 to an operation 30 days after the infarction.3
Such wide variation has created a dilemma in the manage-
ment of these patients. We have previously shown that
patients undergoing CABG after transmural and nontrans-
mural AMI have distinctively different patterns of mortality
with respect to the timing of operative repair.17 The objec-
tive of this study was to delineate the relationship between
mortality and timing of CABG after transmural AMI in a
large and contemporary patient population.
Material and Methods
The data for this report are obtained from the Bureau of Health
Care Research and Information Services, New York State Depart-
ment of Health. The New York State Cardiac Surgery Registry is
a mandatory outcome reporting system that registers every patient
undergoing a cardiac operation, including CABG, within the state.
The data of 105,074 patients who underwent CABG as the sole
procedure from 1991 to 1996 were identified and selected for
analysis. These operations were performed by 179 surgeons at 33
hospitals in New York State. The mean age of the patients was
65  10.2 years (range, 21-95 years). There were 75,829 (72.2%)
male patients and 29,245 (27.83%) female patients. The mean left
ventricular ejection fraction was 46.3% 15.8%. There were 7640
(7.3%) patients undergoing redo CABG.
Data were analyzed with the SAS statistical analysis software
package (SAS Institute, Inc, Cary, NC). Values are expressed as
means  SD unless otherwise specified. Data were first examined
univariately with the Student t test for continuous variables and the
Fisher exact test for discrete data. Other categorical analysis in-
cluded use of the 2 test for trend and Mantel-Haenszel statistics.
For the multivariable analysis, variables with a P value of less than
.25 were entered into a logistic regression analysis model. The risk
factor allowed into the final model with a P value of less than .05
is interpreted as an independent risk factor associated with in-
hospital mortality and adjusted for other potential risk factors
included in the equation.
Results
Among 105,074 patients who underwent CABG as the sole
procedure from 1991 to 1996, 32,123 patients had transmu-
ral AMI before CABG. The timing designation was missing
in 24 patients in this group. Data of the remaining 32,099
patients who had transmural AMI and timing designation
were selected for further analysis. The demographics of
these patients are similar to those of the patient population
as a whole. The mean age of the patients was 64.7  10.3
years (range, 24-95 years). There were 24,146 (75.2%) male
patients and 7953 (24.8%) female patients. The mean left
ventricular ejection fraction was 40.7%  14.1%. There
were 2708 (8.4%) patients undergoing redo CABG.
Overall in-hospital mortality for all patients was 2.7%
versus 3.3% and 2.4% (P  .001) for patients undergoing
CABG with and without a history of transmural AMI,
respectively.
Hospital mortality decreased with increasing time inter-
val between CABG and transmural AMI: 14.2%, 13.8%,
7.9%, 3.8%, 2.9%, and 2.7% for less than 6 hours, 6 hours
to 1 day, 1 to 3 days, 4 to 7 days, 7 to 14 days, and greater
than 15 days, respectively. Mortality is more than double
that of the baseline value when operations are performed
within 3 days of transmural AMI. The graphic representa-
tion of the data is shown in Figure 1. Day 3 appears to be the
point of inflection between the steep rise of mortality in
early surgical intervention versus the lower mortality at the
later time points. Mortality is clearly greater than the base-
Figure 1. Hospital mortality versus timing of CABG. The horizontal bar represents the baseline mortality rate (2.7%)
from the entire patient population.
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line value when surgical intervention is performed within 7
days of transmural AMI.
Table 1 revealed the full list of the 43 potential risk
factors for mortality analyzed in this study. About half of
the potential risks were found to be independently associ-
ated with mortality after multivariate analysis was per-
formed (Table 2). Analysis pertaining to the timing of
surgical intervention suggests that CABG within 3 days of
transmural AMI is independently associated with mortality,
and the odds ratios are 1.6, 2, and 1.5 for less than 6 hours,
6 hours to 1 day, and 1 to 3 days, respectively. Timing of
CABG in and of itself after 3 days of transmural AMI no
longer influenced outcome (Table 2).
Table 3 showed patient demographics and independent
risk factors with the highest odds ratios as a function of
timing of surgical intervention. Although more patients
undergoing early operations were hemodynamically unsta-
ble or in shock, there was no obvious trend with respect to
timing of surgical intervention in the distribution of other
high odds ratio risk factors listed.
Discussion
The surgical management of AMI has been an issue of
ongoing debate. In the setting of AMI and acute coronary
occlusion, there are some who have advocated emer-
gency revascularization,18,19 but others remained uncon-
vinced and suggested a variable period of waiting before
surgical intervention.20-22 Our previous report showed a
significantly higher mortality among patients undergoing
early operations, particularly among those patients with
transmural AMI.17 However, it was not clear precisely at
which point the high mortality associated with early
operations subsided. The magnitude of the New York
State database made it possible to undertake such an
analysis on a day-to-day basis after a transmural AMI.
With this latest analysis, we found that surgical interven-
tion within 3 days of a transmural AMI is independently
associated with mortality. These data provided more sup-
port to those who cautioned against CABG as the acute
and primary course to revascularization in the absence of
ongoing ischemia.
DeWood and colleagues,4,5 in Spokane, Washington,
have been advocates of early operations after transmural
AMI. Their conclusions were derived from a retrospective
study of 440 patients with transmural AMI from 1971 to
1981. In that study it was reported that patients started on
cardiopulmonary bypass within 6 hours of an AMI had
significantly lowered short-term and long-term mortality.
Although these results were impressive, the majority of
these patients only had 1- or 2-vessel disease, and the mean
age of the patients was only 54 years. Their study suggested
that surgical revascularization might be performed with an
acceptable mortality in the presence of AMI with improved
myocardial protection, anesthesia, and surgical techniques.
However, with the advent of thrombolytic therapy, percu-
taneous transluminal coronary angioplasty (PTCA), and an
aged population, the surgical patient we encounter today
bears little resemblance to the patient population repre-
sented in the Spokane data.
A more recent prospective randomized study of 302
patients from 1993 to 1998 by Hochman and colleagues23,24
showed improved survival in patients undergoing early re-
vascularization after AMI complicated by cardiogenic
shock. However, methods of revascularization in this study
included either CABG or PTCA. Furthermore, the design of
this trial would allow up to 54 hours after onset of AMI for
either CABG or PTCA to be performed and still be consid-
ered early revascularization.
Many retrospective studies had been undertaken and
resulted in a wide range of recommendations regarding the
timing of operations and transmural AMI. Dawson and
colleagues3 reviewed 1698 patients in the early 1970s and
recommended a 30-day waiting period. In the 1980s, Gertler
and coworkers15 studied 26 patients with transmural AMI
and proposed a 12-day waiting period. In the 1990s, Deeik
and associates16 advocated a 7-day waiting strategy on the
basis of comparison of 20 patients undergoing CABG with
transmural AMI with patients without AMI. Finally, Brax-
ton and associates8 found 48 hours after a transmural AMI
to be an acceptable timing for CABG by looking at 58
TABLE 1. Potential risk factors analyzed
Age
Female sex
Shock
Ejection fraction 30%
CCS functional class I
CCS functional class II
CCS functional class III
CCS functional class IV
Congestive heart failure
Chronic obstructive
pulmonary disease
Renal failure
CABG 6 h after MI
CABG 6-23 h after MI
CABG 1-3 d after MI
CABG 4-7 d after MI
CABG 8-14 d after MI
Urgent operation
Emergency operation
Aortoiliac disease
Hemodynamically unstable
Intravenous nitroglycerin
administered
preoperatively
Recent smoking history
Reoperation (1 previous heart
operation)
Reoperation (2 or more previous
operations)
No thrombolytic therapy
Calcified aorta
Hypertension
Hepatic failure
Femoral/popliteal disease
Body surface area
Height
Weight
Intra-aortic balloon pump
implanted preoperatively
PTCA before admission
Left ventricular hypertrophy on ECG
Immune system deficiency
Emergency operation after
diagnostic catheterization
Emergency operation after PTCA
PTCA this admission
African American
Hispanic American
Malignant ventricular arrhythmia
Diabetes requiring medication
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patients in the early 1990s. However, no one to date has
reported a study on this topic with a contemporary patient
population approximating the size of our patient population.
In this study we have shown that 3 days after a trans-
mural AMI is a clear dividing line after which timing of
surgical revascularization is no longer associated with mor-
tality. Although the absolute mortality of CABG does not
return to baseline until 7 days after the onset of transmural
AMI, surgical intervention after 3 days shows no trend toward
statistical significance as a potential added risk. Statistically,
the risk of mortality would be the same whether one waits 3
days or 7 days. Early surgical intervention has the advantage of
limiting infarct expansion and adverse ventricular remodel-
ing.25 However, there is a potential risk of ischemia-reper-
fusion injury, which might lead to hemorrhagic infarct ex-
tension, resulting in additional myocardial injury.26
TABLE 2. Multivariate analysis of risk factors in patients with transmural MI
Risk factor P value Odds ratio
95% CI
Lower Upper
Age* .0001 1.557 1.447 1.678
Female sex .0001 1.466 1.275 1.687
Shock .0001 6.204 4.565 8.432
EF 30% .0001 1.420 1.221 1.652
CCS functional class IV .0012 1.345 1.124 1.609
CHF .0001 1.630 1.408 1.887
COPD .0016 1.276 1.097 1.484
Renal failure .0001 3.227 2.637 3.949
CABG 6 h after MI† .0067 1.609 1.141 2.269
CABG 6-23 h after MI† .0010 1.965 1.315 2.935
CABG 1-3 d after MI† .0054 1.529 1.134 2.062
CABG 4-7 d after MI† .7869 1.032 0.819 1.301
CABG 8-14 d after MI† .5615 0.939 0.760 1.161
Urgent operation‡ .0064 1.315 1.080 1.602
Emergency operation‡ .0020 1.534 1.169 2.013
Aortoiliac disease .0001 1.516 1.254 1.835
Hemodynamically unstable .0001 2.263 1.846 2.773
Intravenous NTG preoperatively .0071 1.243 1.061 1.457
Malignant ventricular arrhythmia .0008 1.465 1.171 1.833
Diabetes requiring medication .0001 1.442 1.256 1.657
Reoperation (1 previous heart operation) .0001 3.024 2.527 3.618
Reoperation (2 or more previous operations) .0001 3.180 1.756 5.758
No thrombolytic therapy .0281 1.356 1.033 1.779
Calcified aorta .0001 1.567 1.300 1.888
Hepatic failure .0255 3.112 1.150 8.427
Hosmer and Lemeshow goodness-of-fit test, P  .07. EF, Ejection fraction; CCS, Canadian Cardiovascular Society; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; NTG, nitroglycerin.
*For each additional 10 years of age.
†Compared with CABG greater than 15 days after transmural MI.
‡Compared with elective operations.
TABLE 3. Preoperative risks versus time between CABG and transmural MI
<6 h
(n  564)
6-23 h
(n  333)
1-3 d
(n  946)
4-7 d
(n  3,021)
8-14 d
(n  4,118)
>15 d
(n  23,117)
Age 70 y 31.7% 33.3% 34.5% 34.0% 35.4% 36.5%
Female sex 27.8% 23.4% 25.9% 26.1% 26.6% 24.2%
Shock 29.6% 16.5% 6.5% 1.9% 0.7% 0.3%
Renal failure 2.5% 6.6% 4.0% 3.1% 3.2% 3.6%
Hemodynamically unstable 37.1% 31.2% 18.8% 9.0% 5.7% 3.1%
Reoperation (1 previous heart
operation)
6.6% 6.3% 6.5% 5.2% 4.4% 9.0%
Reoperation (2 or more
previous operations)
0.5% 0.3% 0.3% 0.3% 0.1% 0.6%
Hepatic failure 0.0% 0.6% 0.2% 0.1% 0.2% 0.1%
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It is unclear why surgical intervention within 3 days of
transmural AMI might be an added risk for mortality. It has
been reported that serum C–reactive protein (CRP), a
marker of acute inflammatory response that increases pre-
cipitously after transmural AMI, plateaued on day 3 after
the infarction. In addition, this peak level is a strong indi-
cator of prognosis after a first transmural AMI.27,28 One
might speculate that surgical revascularization within 3 days
of an AMI, during the rising phase of CRP, might further
augment such a systemic inflammatory response and affect
prognosis because CABG is known to cause an increase in
serum CRP level with or without cardiopulmonary bypass.29
A multicenter retrospective study on the basis of a large
database such as ours certainly has its weaknesses. Each
individual surgeon and hospital likely used different proto-
cols and standards relating to surgical techniques, cardio-
pulmonary bypass, and cardioplegic perfusion. Some might
also question the accuracy of data entry. The New York
State Department of Health performs periodic data audits to
identify irregular reporting patterns to ensure data accura-
cy.30 Furthermore, many of the important parameters, such
as mortality rate, used in this study are objective variables
and thus less susceptible to subjective interpretation.
In conclusion, this study revealed that CABG within 3
days of a transmural AMI might be an added risk for
mortality. In the absence of absolute indications for emer-
gency surgical intervention, such as structural complica-
tions and ongoing ischemia, a 3-day waiting period before
CABG should be considered. There are important questions
that remained to be answered, such as the role of thrombo-
lytic therapy, early PTCA, and controlled surgical reperfu-
sion in the management of transmural AMI. These questions
require the cooperation of our cardiology colleagues in
multi-institutional, prospective, randomized clinical trials.
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Discussion
Dr Robert Guyton (Atlanta, Ga). You have answered a ques-
tion that has generally been answered before, although previous
answers have not been as precise nor have they been so firmly
based on such a large series. Indeed, 15 months ago, using a
smaller portion of the same New York State database, your group
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demonstrated that an operation within 24 hours of transmural
infarction was an independent predictor, on the basis of multivar-
iate analysis, of mortality for CABG. Today, with a larger series,
you have extended that time to 3 days after transmural infarction
as an independent predictor of mortality.
My first question is this. Because the mortality for CABG from
days 3 to 7 is about 1.3 times the mortality subsequently, is it not
feasible that an even larger database—for example, collecting this
same data in a national series for 2 or 3 years—might show that an
operation within 1 week might be an independent predictor of
mortality because we have extended with your larger database
from 1 year to the next from 1 day to 3 days? If that is the case and
if we even have, as you point out, a 3% to 5% difference in
mortality, 1.03, if it were significant, would mean that you have
reduced the mortality by 3% by waiting that additional 4 days.
Would it not be feasible to think about collecting that data or even
at this time waiting the additional 4 days?
My second question is based on a concern that you have not
addressed, the more difficult and more penetrating question that we
all face. In a patient who begins to have angina or congestive
failure or even hemodynamic instability after a transmural infarc-
tion in the first few days, when do we advocate medical therapy or
even balloon pump insertion to postpone the operation rather than
proceeding to the operating room? Can your data help us to answer
these questions?
For example, a patient with shock after an AMI has a 60% to
70% mortality with medical therapy. On the basis of your data and
other persons’ data, the mortality is about 20% to 30% or less with
good surgical therapy. Can you use your data to predict mortality
on the basis of multiple preoperative predictors at various times
after transmural infarction and compare that with medical mortal-
ity so that we can make an evidence-based decision as to the risk
and benefit of CABG early after infarction?
We know there is an increased risk of operation in the first few
days compared with operation 2 weeks later. What we need to
know is the relative risk of surgical therapy in the first few days in
a particular patient compared with the medical risk in that same
patient.
Dr Lee. Thank you, Dr Guyton. The paper we presented 15
months ago focused on contrasting the difference in the patterns of
mortality with respect to timing of surgical intervention in trans-
mural and nontransmural myocardial infarction. In that study the
timing of the operation between 1 to 7 days after an AMI was
grouped together, as guided by previous publications. With the
size of the New York State Database, we were able to break up this
subgroup for the first time to analyze mortality on a day-to-day
basis and to obtain statistically significant results.
Since the submission of the initial abstract, we added 2 addi-
tional years of data and found no change in the conclusions.
Statistically, it is unlikely that further extension of the database
will produce different results because the P values and odds ratios
for CABG after 3 days of a transmural AMI showed no trend
toward statistical significance in the multivariate analysis.
In this study we addressed the question of when surgical
revascularization can be performed safely after a transmural AMI.
Surgical intervention after an AMI complicated by congestive
heart failure or cardiogenic shock represents a different patient
population. We are currently working on the latter question.
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